Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Drug Delivery Systems Market Size Changed, over the years?

In recent years, the market size for drug delivery systems has seen significant growth. It’s projected to expand from $41.17 billion in 2024 to $44.21 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. This growth during the historic period can be tied to factors such as an increase in research and development investments, a surge in chronic diseases, growth in biologics and monoclonal antibodies, a high demand for non-invasive delivery methods, as well as a need for enhanced patient compliance and adherence.

How Much Will the Drug Delivery Systems Market Be Worth in 2029?

The market for drug delivery systems is predicted to experience robust growth in the upcoming years, expanding to a worth of $58.64 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. This anticipated growth during the forecast period can be linked to the increasing emphasis on personalized medicine, a growing list of intricate and sensitive drugs in the pipeline, a rise in uncommon and orphan diseases, favorable regulatory environments for novel delivery systems, and an increasing elderly demographic. Main trends expected during this period are the formulation of drug delivery systems based on nanotechnology, advancements in controlled-release and sustained-release technologies, progress in biologics and biosimilars that need specialized delivery, incorporation of intelligent drug delivery devices, and the design of targeted delivery systems for cancer treatment.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24523&type=smp

Which is the Largest Company in the Drug Delivery Systems Market?

Major companies operating in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Tandem Diabetes, Pacira Biosciences, Poseida Therapeutics, Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., VasoRx Inc.

What Are the Main Market Drivers in the Drug Delivery Systems Industry?

The drug delivery systems market is expected to expand due to the growing occurrence of respiratory disorders. Respiratory disorders interfere with the standard functioning of the lungs and airways, leading to breathing difficulties and less oxygen absorption. The escalating levels of air pollution, which continuously expose people to harmful airborne particles and gases, play a part in increasing respiratory disorders, thereby impacting lung function and leading to the progression of respiratory conditions. Drug delivery systems are crucial for effectively treating and managing respiratory afflictions like asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis. These systems ensure that the medication is delivered directly to the lungs, thereby enhancing treatment outcomes and reducing systemic side effects. For example, the UK Health Security Agency, a government body in the UK, reported in March 2025 that tuberculosis cases in England saw a rise of 13%, from 4,850 cases in 2023 to 5,480 cases in 2024. Hence, the surge in respiratory disorders is projected to spur growth in the drug delivery systems market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24523&type=smp

How Is the Drug Delivery Systems Market Segments Structured?

The drug delivery systems market covered in this report is segmented –

1) By Type: Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System

2) By Material: Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems

3) By Application: Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, Other Applications

4) By End-User: Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories

Subsegments:

1) By Injection-Based Drug Delivery System: Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intradermal, Intrathecal, Depot Injections, Needle-Free Injectors

2) By Oral Drug Delivery System: Tablets, Capsules, Solutions And Syrups, Suspensions, Powders And Granules, Modified Release Formulations

3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers, Nasal Sprays

4) By Transmucosal Drug Delivery System: Buccal Delivery, Sublingual Delivery, Rectal Delivery, Vaginal Delivery, Nasal Mucosal Delivery

What Strategic Trends Are Transforming the Drug Delivery Systems Market?

Leading companies in the drug delivery systems market are now prioritizing the development of innovative solutions, such as metal-free, multidose nasal spray pumps, to enhance user comfort and ease of use. These devices have been specifically designed to administer multiple doses of medication through the patient’s nasal passage without relying on any metal parts, guaranteeing both safety and compatibility with a variety of formulations. For example, in January 2023, Aptar Pharma, a pharmaceutical firm based in the US, introduced the APF Futurity metal-free, multidose nasal spray pump. This device is meticulously designed to deliver nasal saline and other related over-the-counter items, with a great emphasis on recyclability. As Aptar Pharma’s first fully recyclable nasal spray pump, it achieved Class AA certification from cyclos-HTP for recycling systems in Europe. Its construction from purely polyolefin materials, devoid of any metal parts or pollutants that may hinder recycling, allows for efficient recycling and enhances the quality of the recyclate. By leveraging Aptar Pharma’s Advanced Preservative Free technology, this metal-free pump guarantees accurate and regular doses through a gentle process, without sacrificing ease of use or performance.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-delivery-systems-global-market-report

Which Global Regions Offer the Highest Growth in the Drug Delivery Systems Market?

North America was the largest region in the drug delivery system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24523

This Report Delivers Insight On:

1. How big is the drug delivery systems market, and how is it changing globally?

2. Who are the major companies in the drug delivery systems market, and how are they performing?

3. What are the key opportunities and risks in the drug delivery systems market right now?

4. Which products or customer segments are growing the most in the drug delivery systems market?

5. What factors are helping or slowing down the growth of the drug delivery systems market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model